Live biotherapeutic products: the importance of a defined regulatory framework

by Magali Cordaillat-Simmons, Alice Rouanet, Bruno Pot
Published 2020-09-01

Prevention and Reversal by Enalapril of Target Organ Damage in Angiotensin II Hypertension

by Caroline Rugale, Magali Cordaillat, Albert Mimran, Bernard Jover
Published 2005-09-01

Entering First-in-Human Clinical Study With a Single-Strain Live Biotherapeutic Product: Input and Feedback Gained From the EMA and the FDA

by Jeanne-Céleste Paquet, Sandrine P. Claus, Magali Cordaillat-Simmons, Wilfrid Mazier, Georges Rawadi, Laure Rinaldi, Frédéric Elustondo, Alice Rouanet
Published 2021-08-01

New insights in the contribution of voltage-gated Na(v) channels to rat aorta contraction.

by Aurélie Fort, Magali Cordaillat, Catherine Thollon, Guillermo Salazar, Ilana Mechaly, Nicole Villeneuve, Jean-Paul Vilaine, Sylvain Richard, Anne Virsolvy
Published 2009-01-01

Live Biotherapeutic Products, A Road Map for Safety Assessment

by Alice Rouanet, Selin Bolca, Audrey Bru, Ingmar Claes, Helene Cvejic, Helene Cvejic, Haymen Girgis, Ashton Harper, Sidonie N. Lavergne, Sophie Mathys, Marco Pane, Bruno Pot, Bruno Pot, Colette Shortt, Wynand Alkema, Constance Bezulowsky, Stephanie Blanquet-Diot, Christophe Chassard, Sandrine P. Claus, Benjamin Hadida, Charlotte Hemmingsen, Cyrille Jeune, Björn Lindman, Garikai Midzi, Luca Mogna, Charlotta Movitz, Nail Nasir, Manfred Oberreither, Jos F. M. L. Seegers, Luc Sterkman, Audrey Valo, Frédérique Vieville, Magali Cordaillat-Simmons
Published 2020-06-01